Central Nervous System Metastases from Triple-Negative Breast Cancer: Current Treatments and Future Prospective

被引：26
作者：
Syriac, Arun Kadamkulam [1 ]
Nandu, Nitish Singh [2 ]
Leone, Jose Pablo [1 ]
机构：
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA
[2] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Hosp & Palliat Med, Bronx, NY 10467 USA
来源：
BREAST CANCER-TARGETS AND THERAPY | 2022年 / 14卷
关键词：
triple-negative breast cancer; metastatic disease; brain metastasis; prognosis clinical outcomes; immunotherapy; stereotactic radiosurgery; whole-brain radiation therapy; antibody-drug conjugate; oligometastatic brain metastasis; clinical outcomes; prediction; prognosis; personalization; multi-omics; machine learning; individualized treatment algorithms; patient benefits; WHOLE-BRAIN RADIOTHERAPY; GRADED PROGNOSTIC ASSESSMENT; PHASE-III TRIAL; FRONT-LINE CHEMOTHERAPY; CELL LUNG-CARCINOMA; SACITUZUMAB GOVITECAN; SURGICAL RESECTION; MALIGNANT-MELANOMA; DOUBLE-BLIND; CAPECITABINE;
D O I：
10.2147/BCTT.S274514
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
It is estimated that approximately one-third of patients with triple-negative breast cancer (TNBC) will develop brain metastases. The prognosis for patients with breast cancer brain metastasis has improved in the recent past, especially for hormone receptor and human epidermal growth factor receptor 2 (HER) positive subtypes. However, the overall survival rate for patients with triple-negative subtype remains poor. The development of newer treatment options, including antibody-drug conjugates such as Sacituzumab govitecan, is particularly encouraging. This article reviews the clinical outcomes, challenges, and current approach to the treatment of brain metastasis in TNBC. We have also briefly discussed newer treatment options and ongoing clinical trials. The development of brain metastasis significantly decreases the quality of life of patients with TNBC, and newer treatment strategies and therapeutics are the need of the hour for this disease subgroup.
引用
收藏
页码：1 / 13
页数：13
相关论文
共 106 条
  • [11] Final efficacy and updated safety results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancer
    Bell, R.
    Brown, J.
    Parmar, M.
    Toi, M.
    Suter, T.
    Steger, G. G.
    Pivot, X.
    Mackey, J.
    Jackisch, C.
    Dent, R.
    Hall, P.
    Xu, N.
    Morales, L.
    Provencher, L.
    Hegg, R.
    Vanlemmens, L.
    Kirsch, A.
    Schneeweiss, A.
    Masuda, N.
    Overkamp, F.
    Cameron, D.
    [J]. ANNALS OF ONCOLOGY, 2017, 28 (04) : 754 - 760
  • [12] Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
    Brastianos, Priscilla K.
    Carter, Scott L.
    Santagata, Sandro
    Cahill, Daniel P.
    Taylor-Weiner, Amaro
    Jones, Robert T.
    Van Allen, Eliezer M.
    Lawrence, Michael S.
    Horowitz, Peleg M.
    Cibulskis, Kristian
    Ligon, Keith L.
    Tabernero, Josep
    Seoane, Joan
    Martinez-Saez, Elena
    Curry, William T.
    Dunn, Ian F.
    Paek, Sun Ha
    Park, Sung-Hye
    McKenna, Aaron
    Chevalier, Aaron
    Rosenberg, Mara
    Barker, Frederick G., II
    Gill, Corey M.
    Van Hummelen, Paul
    Thorner, Aaron R.
    Johnson, Bruce E.
    Hoang, Mai P.
    Choueiri, Toni K.
    Signoretti, Sabina
    Sougnez, Carrie
    Rabin, Michael S.
    Lin, Nancy U.
    Winer, Eric P.
    Stemmer-Rachamimov, Anat
    Meyerson, Matthew
    Garraway, Levi
    Gabriel, Stacey
    Lander, Eric S.
    Beroukhim, Rameen
    Batchelor, Tracy T.
    Baselga, Jose
    Louis, David N.
    Getz, Gad
    Hahn, William C.
    [J]. CANCER DISCOVERY, 2015, 5 (11) : 1164 - 1177
  • [13] Delivery and activity of SN-38 by sacituzumab govitecan in CNS tumours
    Brenner, A. J.
    Pandey, R.
    Chiou, J.
    Floyd, J.
    Garcia, M.
    Surapaneni, P.
    Kaklamani, V.
    Lathrop, K.
    Crownover, R.
    Caron, J. L.
    Tiziani, S.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S401 - S401
  • [14] Understanding patterns of brain metastasis in breast cancer and designing rational therapeutic strategies
    Brosnan, Evelyn M.
    Anders, Carey K.
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (09)
  • [15] Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001
    Brown, Paul D.
    Gondi, Vinai
    Pugh, Stephanie
    Tome, Wolfgang A.
    Wefel, Jeffrey S.
    Armstrong, Terri S.
    Bovi, Joseph A.
    Robinson, Cliff
    Konski, Andre
    Khuntia, Deepak
    Grosshans, David
    Benzinger, Tammie L. S.
    Bruner, Deborah
    Gilbert, Mark R.
    Roberge, David
    Kundapur, Vijayananda
    Devisetty, Kiran
    Shah, Sunjay
    Usuki, Kenneth
    Anderson, Bethany Marie
    Stea, Baldassarre
    Yoon, Harold
    Li, Jing
    Laack, Nadia N.
    Kruser, Tim J.
    Chmura, Steven J.
    Shi, Wenyin
    Deshmukh, Snehal
    Mehta, Minesh P.
    Kachnic, Lisa A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (10) : 1019 - +
  • [16] Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC.3): a multicentre, randomised, controlled, phase 3 trial
    Brown, Paul D.
    Ballman, Karla V.
    Cerhan, Jane H.
    Anderson, S. Keith
    Carrero, Xiomara W.
    Whitton, Anthony C.
    Greenspoon, Jeffrey
    Parney, Ian F.
    Laack, Nadia N. I.
    Ashman, Jonathan B.
    Bahary, Jean-Paul
    Hadjipanayis, Costas G.
    Urbanic, James J.
    Barker, Fred G., II
    Farace, Elana
    Khuntia, Deepak
    Giannini, Caterina
    Buckner, Jan C.
    Galanis, Evanthia
    Roberge, David
    [J]. LANCET ONCOLOGY, 2017, 18 (08) : 1049 - 1060
  • [17] Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases A Randomized Clinical Trial
    Brown, Paul D.
    Jaeckle, Kurt
    Ballman, Karla V.
    Farace, Elana
    Cerhan, Jane H.
    Anderson, S. Keith
    Carrero, Xiomara W.
    Barker, Fred G., II
    Deming, Richard
    Burri, Stuart H.
    Menard, Cynthia
    Chung, Caroline
    Stieber, Volker W.
    Pollock, Bruce E.
    Galanis, Evanthia
    Buckner, Jan C.
    Asher, Anthony L.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (04): : 401 - 409
  • [18] RIBBON-2: A Randomized, Double-Blind, Placebo-Controlled, Phase III Trial Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy for Second-Line Treatment of Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer
    Brufsky, Adam M.
    Hurvitz, Sara
    Perez, Edith
    Swamy, Raji
    Valero, Vicente
    O'Neill, Vincent
    Rugo, Hope S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (32) : 4286 - 4293
  • [19] Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial
    Chang, Eric L.
    Wefel, Jeffrey S.
    Hess, Kenneth R.
    Allen, Pamela K.
    Lang, Frederick F.
    Kornguth, David G.
    Arbuckle, Rebecca B.
    Swint, J. Michael
    Shiu, Almon S.
    Maor, Moshe H.
    Meyers, Christina A.
    [J]. LANCET ONCOLOGY, 2009, 10 (11) : 1037 - 1044
  • [20] Chang WC, 2014, KOREAN J CLIN ONCOL, V10, P103, DOI [10.14216/kjco.14019, DOI 10.14216/KJCO.14019]
12345678910